Cargando…

Poster 2022: Sublingual immunotherapy in the treatment of allergic rhinitis: series of cases

Detalles Bibliográficos
Autores principales:	Gonzalez-Diaz, Sandra Nora, Arias-Cruz, Alfredo, Rangel-Garza, Lorena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Allergy Organization 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082046/ http://dx.doi.org/10.1186/1939-4551-7-S1-P28

Ejemplares similares

Poster 1014: Omalizumab efficiency in patients with allergic rhinitis and chronic sinusitis
por: Gonzalez-Diaz, Sandra Nora, et al.
Publicado: (2014)

Poster 2021: The incidence of adverse reactions induced by subcutaneous immunotherapy in an allergy center in Monterrey, México: a retrospective chart review
por: Gonzalez-Diaz, Sandra Nora, et al.
Publicado: (2014)

Sublingual immunotherapy in allergic rhinitis
por: Han, Doo Hee, et al.
Publicado: (2011)

Poster 2016: The effect and value of sublingual immunotherapy: a patient survey
por: Morris, Mary S, et al.
Publicado: (2014)

Poster 1008: Dialyzable leukocyte extracts as adjuvant treatment for allergic rhinitis
por: Homberg, Toni Angela, et al.
Publicado: (2014)

Submission for: Poster presentation at ANCIPS 2022: Allergic dermatitis with use of sublingual Buprenorphine: A rare case report
por: Gracy*, Dr BK, et al.
Publicado: (2022)

Sublingual Immunotherapy in Allergic Rhinitis: Efficacy, Safety, Adherence and Guidelines
por: Aboshady, Omar Ali, et al.
Publicado: (2014)

Effect of sublingual immunotherapy on platelet activity in children with allergic rhinitis()
por: Chen, Yanqiu, et al.
Publicado: (2016)

Nasal microbes in allergic rhinitis children with or without sublingual immunotherapy
por: Shen, Xiao-Fei, et al.
Publicado: (2023)

Efficacy and immunological changes of sublingual immunotherapy in pediatric allergic rhinitis
por: Zeng, Yinhui, et al.
Publicado: (2023)

Poster 1000: Efficacy and safety of specific sublingual immunotherapy with carbamylated allergoid tablets of ragweed pollen: a dose-ranging study
por: Compalati, Enrico, et al.
Publicado: (2014)

The current role of sublingual immunotherapy in the treatment of allergic rhinitis in adults and children
por: Incorvaia, Cristoforo, et al.
Publicado: (2011)

Preference for sublingual immunotherapy with tablets in a Spanish population with allergic rhinitis
por: Bøgelund, Mette, et al.
Publicado: (2022)

Sublingual immunotherapy increases Treg/Th17 ratio in allergic rhinitis
por: Wang, Jiarong, et al.
Publicado: (2021)

Outcome of Sublingual Immunotherapy in Patients With Allergic Rhinitis Sensitive to House Dust Mites
por: Kim, Seon-Tae
Publicado: (2015)

Acupuncture as an add-on therapy to sublingual allergen-specific immunotherapy for patients with allergic rhinitis
por: Li, Jiang-hua, et al.
Publicado: (2019)

Pharmacoeconomics of sublingual immunotherapy with the 5-grass pollen tablets for seasonal allergic rhinitis
por: Lombardi, Carlo, et al.
Publicado: (2017)

Malaysian Society of Allergy and Immunology Consensus Statement on Sublingual Immunotherapy in Allergic Rhinitis
por: Abdullah, Baharudin, et al.
Publicado: (2023)

Efficacy and safety of sublingual immunotherapy for allergic rhinitis: A network meta-analysis
por: Ji, Zao, et al.
Publicado: (2023)

Poster 1020: Efficacy and safety of sublingual specific immunotherapy with Pru p 3 in a portuguese population - clinical and immunological evaluation during 12 months
por: Costa, Ana Célia, et al.
Publicado: (2014)

Observational study: evaluating symptom control in allergic rhinitis at three years after starting immunotherapy
por: Droessaert, Valerie, et al.
Publicado: (2013)

Early Compliance and Efficacy of Sublingual Immunotherapy in Patients with Allergic Rhinitis for House Dust Mites
por: Chang, Hyun, et al.
Publicado: (2009)

New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis
por: Frati, Franco, et al.
Publicado: (2014)

Artemisia Annua sublingual immunotherapy for seasonal allergic rhinitis: A multicenter, randomized trial
por: Lou, Hongfei, et al.
Publicado: (2020)

Predictors for Short-Term Efficacy of Allergen-Specific Sublingual Immunotherapy in Children with Allergic Rhinitis
por: Liu, Wenlong, et al.
Publicado: (2020)

Incidence and gravity of COVID-19 in patients with allergic rhinitis under treatment with sublingual immunotherapy
por: De Oliveira Santos, Júlia Gaspar, et al.
Publicado: (2022)

Cockroach sensitivity in allergic rhinitis patients; is it significant? To see prevalence of cockroach sensitivity in allergic rhinitis patients in Kingston area
por: Batool, Tahira, et al.
Publicado: (2010)

New insights into the pathogenesis of non-allergic rhinitis
por: Segboer, Christine, et al.
Publicado: (2015)

Sublingual or Subcutaneous immunotherapy for Seasonal Allergic Rhinitis (AR): an indirect analysis of efficacy, safety and cost
por: Dranitsaris, George, et al.
Publicado: (2014)

New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Corrigendum]
Publicado: (2015)

The relationship between sublingual immunotherapy for allergic rhinitis and the risk of symptoms in patients with COVID-19 infection
por: Zhang, Shipeng, et al.
Publicado: (2023)

Dropouts From Sublingual Immunotherapy and the Transition to Subcutaneous Immunotherapy in House Dust Mite-Sensitized Allergic Rhinitis Patients
por: Chen, Huan, et al.
Publicado: (2022)

Chinese Guideline on Allergen Immunotherapy for Allergic Rhinitis: The 2022 Update
por: Wang, Chengshuo, et al.
Publicado: (2022)

The effect of nasal breathing on the exercise induced bronchospasm in children with allergic asthma and rhinitis
por: Turkalj, Mirjana, et al.
Publicado: (2013)

PD14 - Non-interventional 2-year study of sublingual immunotherapy in children and adolescents with allergic rhinoconjunctivitis caused by grass pollen
por: Karagiannis, Efstrathios, et al.
Publicado: (2014)

Relevant Patient Benefit of Sublingual Immunotherapy with Birch Pollen Allergen Extract in Allergic Rhinitis: An Open, Prospective, Non-Interventional Study
por: Blome, Christine, et al.
Publicado: (2020)

Circulating MMP-12 as Potential Biomarker in Evaluating Disease Severity and Efficacy of Sublingual Immunotherapy in Allergic Rhinitis
por: Zhou, Yandan, et al.
Publicado: (2022)

Allergic rhinitis in the primary care setting: patient practice reflective
por: Small, Peter, et al.
Publicado: (2010)

The (potential) role of apolipoproteins in nasal mucus of allergic rhinitis patients
por: Tomazic, Peter, et al.
Publicado: (2014)

Poster 2013: The safety of the united allergy services immunotherapy protocol
por: Schaffer, Frederick, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_9pv63qqmuovkutpn73s33ds27e